CLINICAL EXPERIENCE WITH ETANERCEPT IN THE TREATMENT OF PATIENTS WITH ANKYLOSING SPONDYLITIS

QR Code

CLINICAL EXPERIENCE WITH ETANERCEPT IN THE TREATMENT OF PATIENTS WITH ANKYLOSING SPONDYLITIS

Etanercept (ETC), a soluble tumor necrosis factor-α (TNF-α) receptor, was registered for the treatment of spondyloarthritis in the Russian Federation in 2009. By now, results of prolonged treatment with this drug have been obtained in patients with ankylosing spondylitis (AS).Objective: to evaluate...

Full description

Saved in:

Bibliographic Details
Main Authors:	O. A. Rumyantseva, A. G. Bochkova, M. M. Urumova, T. V. Dubinina, Sh. F. Erdes
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2018-05-01
Series:	Научно-практическая ревматология
Subjects:	etanercept ankylosing spondylitis axial spondyloarthritis remission
Online Access:	https://rsp.mediar-press.net/rsp/article/view/2524
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Experience of etanercept treatment in juvenile ankylosing spondyloarthritis
by: A. N. Fetisova, et al.
Published: (2013-03-01)

Remission in ankylosing spondylitis and axial spondyloarthritides: A modern understanding of the problem
by: I. Z. Gaydukova, et al.
Published: (2016-03-01)

USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS FOR THE TREATMENT OF AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS, MONITORING THEIR EFFICACY AND SAFETY (DRAFT GUIDELINES OF THE EXPERT SPONDYLOARTHRITIS DIAGNOSIS AND TREATMENT GROUP)
by: I. Z. Gaidukova, et al.
Published: (2016-09-01)

Experience with long-term infliximab therapy in patients with ankylosing spondylitis
by: Oksana Alekseevna Rumyantseva, et al.
Published: (2010-12-01)

REMISSION IN AXIAL SPONDYLOARTHRITIS: DEFINITION AND EVALUATION TOOLS (RECOMMENDATIONS OF THE SPONDYLOARTHRITIS STUDY GROUP OF EXPERTS, ALL-RUSSIAN PUBLIC ORGANIZATION «THE ASSOCIATION OF RHEUMATOLOGY OF RUSSIA»)
by: I. Z. Gaidukova, et al.
Published: (2018-03-01)

Etanercept in axial spondyloarthritis – treatment efficacy
by: I. Z. Gaydukova, et al.
Published: (2022-03-01)

Specific features of axial spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, in persons of different genders
by: A. P. Rebrov, et al.
Published: (2015-03-01)

Disease activity and two-year sacroiliac joint changes according to instrumental study findings in a CoRSAr cohort of patients with early axial spondyloarthritis
by: Sh. Erdes, et al.
Published: (2019-05-01)

THE NEED AND POSSIBILITIES OF EARLY DIAGNOSIS OF ANKYLOSING SPONDYLITIS: COMMENTARIES ON THE PAPER «EARLY DIAGNOSIS OF ANKYLOSING SPONDYLITIS» (No. 4, 2013) AND DISCUSSION IN THE JOURNAL (No. 2, 2014)
by: Sh. F. Erdes
Published: (2014-09-01)

COMPARATIVE ANALYSIS OF MAIN CLINICAL MANIFESTATIONS IN MALES AND FEMALES WITH EARLY AXIAL SPONDYLOARTHRITIS
by: D. G. Rumyantseva, et al.
Published: (2019-09-01)

COMPARATIVE EVALUATION OF PATIENTS WITH ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS
by: I. А. Cherentsova, et al.
Published: (2016-09-01)

ASSESSMENT OF COXITIS PROGRESSION IN EARLY AXIAL SPONDYLOARTHRITIS
by: E. M. Agafonova, et al.
Published: (2020-04-01)

THE EVOLUTION OF AXIAL SPONDYLOARTHRITIS DURING 12-MONTH FOLLOW-UP STUDY OF A CORSAR COHORT
by: Sh. F. Erdes, et al.
Published: (2016-09-01)

Anti-CD74 IGA antibodies, genetic polymorphisms and inflammatory activity in ankylosing spondylitis
by: V. I. Mazurov, et al.
Published: (2021-01-01)

Long-term efficacy and safety of netakimab in the treatment of ankylosing spondylitis: results of Phase III international, multicenter, randomized double-blind clinical trial BCD-085-5/ASTERA
by: V. I. Mazurov, et al.
Published: (2020-11-01)

Efficacy of golimumab in treating uveitis in patients with ankylosing spondylitis
by: T. V. Dubinina, et al.
Published: (2016-09-01)

Time course of radiographic hip joint changes in patients with early axial spondyloarthritis
by: E. M. Agafonova, et al.
Published: (2021-02-01)

DRAFT «ASPINE» MOBILE APPLICATION FOR PATIENTS WITH EARLY AXIAL SPONDYLOARTHRITIS
by: D. G. Rumiantceva, et al.
Published: (2018-01-01)

Axial spondyloarthritis: a current look at the concept and evolution of the disease
by: D. G. Rumyantseva, et al.
Published: (2019-10-01)

Features of ankylosing spondylitis at different stages in men and women
by: I. A. Cherentsova, et al.
Published: (2019-05-01)

Factors of coxitis progression in patients with axial spondyloarthritis. Results of a two-year dynamic observation
by: E. M. Agafonova, et al.
Published: (2024-12-01)

TUMOR NECROSIS FACTOR-α INHIBITORS IN THE TREATMENT OF AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS
by: S. A. Lapshina, et al.
Published: (2016-09-01)

Ankylosing spondylitis morbidity trends in Russia and Saturday spondyloarthritis schools
by: Shandor Fedorovich Erdes, et al.
Published: (2013-04-01)

Recent advances and prospects of axial spondyloarthritis / ankylosing spondylitis treatment
by: Sh. F. Erdes
Published: (2021-04-01)

Progression of sacroiliitis in men and women according to the cohort of early axial spondyloarthritis (CORSAR) over 3 years of follow-up
by: D. G. Timokhina, et al.
Published: (2021-12-01)

Evaluation of the possibility of axial psoriatic arthritis patients meet classification criteria for axial spondyloarthritis and ankylosing spondylitis
by: E. E. Gubar, et al.
Published: (2023-08-01)

COURSE OF UVEITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: A. A. Godzenko, et al.
Published: (2016-09-01)

EXPERIENCE WITH RITUXIMAB IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: Mikhail Sergeyevich Protopopov, et al.
Published: (2013-02-01)

Radiologic methods as a tool for monitoring axial spondyloarthritis in real clinical practice
by: T. V. Dubinina, et al.
Published: (2022-02-01)

Real-world retention rate, effectiveness, and safety of netakimab in the treatment of patients with ankylosing spondylitis: Two-year results of the real word evidence LIBRA study
by: Sh. F. Erdes, et al.
Published: (2025-07-01)

LABORATORY BIOMARKERS FOR ANKYLOSING SPONDYLITIS
by: E. N. Aleksandrova, et al.
Published: (2017-03-01)

OSTEOPOROSIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: Elena Efimovna Gubar, et al.
Published: (2013-12-01)

Inflammatory and post-inflammatory lesions in the sacroiliac joints and lumbar spine according to magnetic resonance imaging in patients with early axial spondyloarthritis
by: D. G. Rumyantseva, et al.
Published: (2019-03-01)

Axial spondyloarthritis and COVID-19: course, interactions, outcomes, and the role of vaccination
by: Sh. F. Erdes, et al.
Published: (2023-02-01)

Features of coxitis treatment in patients with ankylosing spondylitis
by: E. M. Agafonova, et al.
Published: (2018-06-01)

Clinical features of ankylosing spondylitis in patients with secondary AA amyloidosis
by: D. G. Rumyantseva, et al.
Published: (2020-09-01)

Efficacy and safety of a new original interleukin 17A inhibitor in the treatment of patients with active ankylosing spondylitis: results of a basic (BCD-085-3/AILAS) and extended (BCD-085-3ext/AILAS-II) phase II clinical trial
by: Sh. Erdes, et al.
Published: (2019-12-01)

Magnetic resonance tomography capabilities and limitations in managing the efficacy of treatment with biological disease modifying anti-rheumatic drugs in ankylosing spondylitis
by: P. A. Shesternya, et al.
Published: (2021-04-01)

THE FIRST EXPERIENCE IN USING ADALIMUMAB IN PATIENTS WITH ANKYLOSING SPONDYLITIS: CLINICAL AND MRICOMPARISONS OF THE RESULTS OF THERAPY
by: A G Bochkova, et al.
Published: (2010-02-01)

Efficacy and safety of netakimab, anti-IL-17A monoclonal antibody, in patients with ankylosing spondylitis. Results of phase III international, multicenter, randomized double-blind clinical trial BCD-085-5/ASTERA
by: V. I. Mazurov, et al.
Published: (2020-09-01)